{
    "title": "103_hr760",
    "content": "TITLE I--BIOTECHNOLOGICAL PROCESS PATENTS\n\nSEC. 101. CONDITIONS FOR PATENTABILITY; NONOBVIOUS SUBJECT MATTER.\n\n    Section 103 of title 35, United States Code, is amended--\n            (1) in the first unnumbered paragraph by inserting ``(a)'' \n        before ``A patent'';\n            (2) in the second unnumbered paragraph by inserting ``(b)'' \n        before ``Subject matter''; and\n            (3) by adding at the end thereof the following new \n        subsections:\n    ``(c) Notwithstanding any other provision of this section, a \nclaimed process of making or using a machine, manufacture, or \ncomposition of matter is not obvious under this section if--\n            ``(1) the machine, manufacture, or composition of matter is \n        novel under section 102 of this title and nonobvious under this \n        section;\n            ``(2) the claimed process is a biotechnological process as \n        defined in subsection (d); and\n            ``(3)(A) the machine, manufacture, or composition of \n        matter, and the claimed process invention at the time it was \n        made, were owned by the same person or subject to an obligation \n        of assignment to the same person; and\n            ``(B) claims to the process and to the machine, \n        manufacture, or composition of matter--\n                    ``(i) are entitled to the same effective filing \n                date; and\n                    ``(ii) appear in the same patent application, \n                different patent applications, or patent which is owned \n                by the same person and which expires or is set to \n                expire on the same date.\n    ``(d) For purposes of this section, the term `biotechnological \nprocess' means any method of making or using living organisms, or parts \nthereof, for the purpose of making or modifying products. Such term \nincludes recombinant DNA, recombinant RNA, cell fusion including \nhybridoma techniques, and other processes involving site specific \nmanipulation of genetic material.''.\n\nSEC. 102. NO PRESUMPTION OF INVALIDITY.\n\n    The first unnumbered paragraph of section 282 of title 35, United \nStates Code, is amended by inserting after the second sentence ``A \nclaim issued under the provisions of section 103(c) of this title on a \nprocess of making or using a machine, manufacture, or composition of \nmatter shall not be held invalid under section 103 of this title solely \nbecause the machine, manufacture, or composition of matter is \ndetermined to lack novelty under section 102 of this title or to be \nobvious under section 103 of this title.''.\n\nSEC. 103. EFFECTIVE DATE.\n\n    The amendments made by this title shall apply to all United States \npatents granted on or after the date of the enactment of this Act and \nto all applications for United States patents pending on or filed after \nsuch date of enactment, including any application for the reissuance of \na patent.\n\n              TITLE II--BIOTECHNOLOGICAL MATERIAL PATENTS\n\nSEC. 201. INFRINGEMENT BY IMPORTATION, SALE OR USE.\n\n    (a) Infringement.--Section 271 of title 35, United States Code, is \namended by adding at the end the following new subsection:\n    ``(h) Whoever without authority imports into the United States or \nsells or uses within the United States a product which is made by using \na biotechnological material (as defined under section 154(b)) which is \npatented in the United States shall be liable as an infringer if the \nimportation, sale, or use of the product occurs during the term of such \npatent.''.\n    (b) Contents and Term Patent.--Section 154 of title 35, United \nStates Code, is amended--\n            (1) by inserting ``(a)'' before ``Every'';\n            (2) by striking out ``in this title,'' and inserting in \n        lieu thereof ``in this title (1)'';\n            (3) by striking out ``and, if the invention'' and inserting \n        ``(2) if the invention'';\n            (4) by inserting after ``products made by that process,'' \n        the following: ``and (3) if the invention is a biotechnological \n        material used in making a product, of the right to exclude \n        others from using or selling throughout the United States, or \n        importing into the United States the product made or using such \n        biotechnological material,''; and\n            (5) by adding at the end thereof the following:\n    ``(b) For purposes of this section, the term `biotechnological \nmaterial' is defined as any material (including a host cell, DNA \nsequence, or vector) that is used in a biotechnological process as \ndefined under section 103(d).''.\n    (c) Effective Date.--\n            (1) In general.--The amendment made by this section shall \n        take effect six months after the date of enactment of this Act \n        and, subject to paragraph (2), shall apply only with respect to \n        products made or imported after the effective date of the \n        amendments made by this section.\n            (2) Exceptions.--The amendments made by this section shall \n        not abridge or affect the right of any person, or any successor \n        to the business of such person--\n                    (A) to continue to use, sell, or import products in \n                substantial and continuous sale or use by such person \n                in the United States on the date of enactment of this \n                Act; or\n                    (B) to continue to use, sell, or import products \n                for which substantial preparation by such person for \n                such sale or use was made before such date, to the \n                extent equitable for the protection of commercial \n                investment made or business commenced in the United \n                States before such date."
}